United States

People: Koninklijke DSM NV (RDSMY.PK)

RDSMY.PK on OTC Markets Group

22 Jul 2016
Change (% chg)

$0.09 (+0.61%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

de Swaan, Tom 

Dr. Tom de Swaan has served as Member of the Supervisory Board of Koninklijke DSM NV since March 29, 2006. He is currently retired. The last position he held was Member of the Managing Board and Chief Financial Officer/Chief Risk Officer ABN AMRO. Dr. de Swaan also serves as Non-Executive Director of the Board of GlaxoSmithKline Plc and of the Board of Zurich Financial Services, Chairman of the Supervisory Board of Van Lanschot Bankiers N.V., Vice Chairman of the Supervisory Board of Royal Ahold N.V., Board Member of Royal Concertgebouw Orchestra and Member of the Board of Trustees of Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, as well as Chairman Advisory Board Rotterdam School of Management. Dr. de Swaan is Chairman of the Company's Audit Committee and Member of Remuneration Committee. He graduated from University of Amsterdam with a degree in Economics.

Basic Compensation

Total Annual Compensation, EUR 67,500
Restricted Stock Awards, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR 6,151
Fiscal Year Total, EUR 73,651

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --